Business Daily from THE HINDU group of publications
Sunday, May 20, 2007
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Courts/Legal Issues
Court order allows Dr Trehan to continue at Escorts Heart

Our Bureau

`My contract is up to 2010; it can't be terminated'

New Delhi May 19 Dr Naresh Trehan, the visible face of Escorts Heart Institute and Research Centre (EHRIC), has challenged calls for his removal by Fortis Health Care, the present promoters of the Capital's leading super-speciality hospital.

The cardiologist, who is Executive Director and owns 10 per cent stake in EHRIC, was on Saturday morning barred from entering the hospital premises.

The day began with high drama at the institution, with relatives of the patients protesting security personnel stopping Dr Trehan from entering the operation theatre. The police was also called in.

Though a Fortis' spokesperson said that Dr Trehan's administrative powers have been ``terminated'', the doctor said that the management did not have the powers to do so. He cited the status quo ordered by the Delhi High Court in the case related to sale of EHIRC, which was set up by the Escorts Group.

``My contract was with the EHIRC society for 20 years, from 1990 up to 2010. As per the HC order on maintaining status quo, the Fortis management cannot terminate the contract,'' Dr Trehan said.

Mr Anil Nanda of the Escorts family moved the courts against Fortis' action, which allowed Dr Trehan to continue his work at EHRIC. The bone of contention between the Fortis management and Dr Trehan has been over the Medicity projects to come up in Gurgaon. Both Dr Trehan and Fortis had announced their intention to set up large healthcare projects there.

According to the spokesperson, Fortis has been negotiating for a partnership in Dr Trehan's over Rs 100-crore, 2,000-bed, Medicity project which is being planned on the lines of the John Hopkins Institute, US. The company had earlier admitted that two similar projects of such a large magnitude, and planned for the same city, did not make commercial sense.

The drama unfolded late Friday evening when the Ranbaxy-promoted company, through an official communiqué quoting Fortis Hospital's Managing Director, Mr Shivinder Singh, informed the media that Dr Trehan had relinquished his post of Executive Director of EHRIC.

According to the Fortis spokesperson, Dr Trehan, working on his Medicity in his private capacity amounted to a conflict of interest. "You can't have your full time Executive Director setting out as a promoter of a competitive project," the spokesperson said. Fortis, which has filed a police complaint against Dr Trehan, is confident that EHRIC will retain its trust with patients. "We have a team of doctors with strong clinical-care strengths, that Dr Trehan has trained," the spokesperson added.

More Stories on : Courts/Legal Issues | People | Medical Institutions & Hospitals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Court order allows Dr Trehan to continue at Escorts Heart


`Demergers unlock value for shareholders'
Two negative surprises in Bajaj demerger
No immediate plan to merge with IOC: Chennai Petro MD
Haryana project
Continental Automotive plans production unit here
Tata Power eyes coal from Australia, S. Africa
Ranbaxy gets tentative USFDA nod for Allegra
Deyaar, Ansal township may come up in UP
Singapore firm Jurong roped in for Vizag township
L&T bets big on formal skills training for workers
Fortune Park plans more properties
HEG eyes Rs 1,200-crore turnover this fiscal
Atul Auto targets wider market for rear-engine three-wheelers
Spentex appoints directors


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line